NASDAQ:HQYHealthequity Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Healthequity Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $41.09 -2.80 (-6.38 %) (As of 04/5/2020 11:39 AM ET) Add Compare Share Today's Range$40.56Now: $41.09▼$45.3750-Day Range$40.54MA: $61.77▼$87.7352-Week Range$34.40Now: $41.09▼$88.78Volume618,514 shsAverage Volume1.45 million shsMarket Capitalization$2.91 billionP/E Ratio63.22Dividend YieldN/ABeta1.57 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media HealthEquity, Inc. provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers health reimbursement and flexible spending arrangements solutions; and Employee Retirement Income Security Act's plan administration and investment services. HealthEquity, Inc. was founded in 2002 and is headquartered in Draper, Utah.Read More Beat the Market (BTM) Rank™ 4.5 Analyst's Opinion Consensus RatingHealthequity has received a consensus rating of Buy. The company's average rating score is 2.92, and is based on 10 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $70.83, Healthequity has a potential upside of 72.4% from its current price of $41.09.Amount of Analyst CoverageHealthequity has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 2.8 Community Rank Outperform VotesHealthequity has received 443 “outperform” votes. (Add your “outperform” vote.)Underperform VotesHealthequity has received 347 “underperform” votes. (Add your “underperform” vote.)Community SentimentHealthequity has received 56.08% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Healthequity and other stocks. Vote “Outperform” if you believe HQY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe HQY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldHealthequity does not currently pay a dividend.Dividend GrowthHealthequity does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Healthequity insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,649,496.00 in company stock.Percentage Held by InsidersOnly 3.70% of the stock of Healthequity is held by insiders.Percentage Held by Institutions99.08% of the stock of Healthequity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Healthequity are expected to grow by 41.27% in the coming year, from $1.26 to $1.78 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Healthequity is 63.22, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 10.11.Price to Earnings Ratio vs. SectorThe P/E ratio of Healthequity is 63.22, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 12.15.Price to Earnings Growth RatioHealthequity has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthequity has a P/B Ratio of 2.83. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 4.5Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.03 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HQY Previous Symbol CUSIPN/A CIK1428336 Webhttp://www.healthequity.com/ Phone801-727-1000Debt Debt-to-Equity Ratio1.21 Current Ratio1.96 Quick Ratio1.91Price-To-Earnings Trailing P/E Ratio63.22 Forward P/E Ratio32.61 P/E Growth1.54 Sales & Book Value Annual Sales$531.99 million Price / Sales5.47 Cash Flow$1.98 per share Price / Cash Flow20.74 Book Value$14.54 per share Price / Book2.83Profitability EPS (Most Recent Fiscal Year)$1.38 Net Income$39.66 million Net Margins7.46% Return on Equity10.54% Return on Assets5.55%Miscellaneous Employees1,141 Outstanding Shares70,880,000Market Cap$2.91 billion Next Earnings Date6/2/2020 (Estimated) OptionableOptionable Receive HQY News and Ratings via Email Sign-up to receive the latest news and ratings for HQY and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:HQY Rates by TradingView Healthequity (NASDAQ:HQY) Frequently Asked Questions How has Healthequity's stock been impacted by COVID-19 (Coronavirus)? Healthequity's stock was trading at $50.32 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, HQY shares have decreased by 18.3% and is now trading at $41.09. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Healthequity? 13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Healthequity in the last year. There are currently 2 hold ratings, 10 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Healthequity. When is Healthequity's next earnings date? Healthequity is scheduled to release its next quarterly earnings announcement on Tuesday, June 2nd 2020. View our earnings forecast for Healthequity. How were Healthequity's earnings last quarter? Healthequity Inc (NASDAQ:HQY) issued its quarterly earnings data on Monday, March, 16th. The company reported $0.39 EPS for the quarter, topping the consensus estimate of $0.23 by $0.16. The company had revenue of $201.20 million for the quarter, compared to the consensus estimate of $199.95 million. Healthequity had a net margin of 7.46% and a return on equity of 10.54%. The company's revenue for the quarter was up 165.4% on a year-over-year basis. During the same period last year, the company earned $0.21 earnings per share. View Healthequity's earnings history. What guidance has Healthequity issued on next quarter's earnings? Healthequity updated its FY21 earnings guidance on Monday, March, 16th. The company provided earnings per share (EPS) guidance of $1.70-$1.81 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.80. The company issued revenue guidance of $770-$790 million, compared to the consensus revenue estimate of $824.18 million. What price target have analysts set for HQY? 13 Wall Street analysts have issued 1 year price objectives for Healthequity's stock. Their forecasts range from $47.00 to $90.00. On average, they anticipate Healthequity's share price to reach $70.83 in the next twelve months. This suggests a possible upside of 72.4% from the stock's current price. View analysts' price targets for Healthequity. Has Healthequity been receiving favorable news coverage? News coverage about HQY stock has trended very negative this week, InfoTrie Sentiment reports. The research firm identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Healthequity earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View the latest news aboutHealthequity. Are investors shorting Healthequity? Healthequity saw a increase in short interest in March. As of March 13th, there was short interest totaling 4,841,900 shares, an increase of 26.1% from the February 27th total of 3,840,000 shares. Based on an average trading volume of 1,197,000 shares, the short-interest ratio is presently 4.0 days. Approximately 7.0% of the company's shares are sold short. View Healthequity's Current Options Chain. Who are some of Healthequity's key competitors? Some companies that are related to Healthequity include Trip.com Group (TCOM), Ctrip.Com International (CTRP), Broadridge Financial Solutions (BR), Fair Isaac (FICO), The Western Union (WU), LYFT (LYFT), Zillow Group (Z), Zillow Group (ZG), Nielsen (NLSN), WEX (WEX), Etsy (ETSY), Ritchie Bros. Auctioneers (RBA), CDK Global (CDK), MAXIMUS (MMS) and GrubHub (GRUB). What other stocks do shareholders of Healthequity own? Based on aggregate information from My MarketBeat watchlists, some companies that other Healthequity investors own include NVIDIA (NVDA), Input Capital (INP), Circle Oil (COP), Shopify (SHOP), Alibaba Group (BABA), Paypal (PYPL), Twilio (TWLO), Square (SQ), Netflix (NFLX) and Okta (OKTA). Who are Healthequity's key executives? Healthequity's management team includes the following people: Mr. Jon Kessler, Pres, CEO & Director (Age 51)Stephen D. Neeleman, Founder & Vice Chairman (Age 51)Mr. Darcy G. Mott, Exec. VP & CFO (Age 66)Ms. Ashley Dreier, Exec. VP, CTO & Chief Information Officer (Age 46)Mr. William Robert Otten, Exec. VP of Sales (Age 54) What is Healthequity's stock symbol? Healthequity trades on the NASDAQ under the ticker symbol "HQY." How do I buy shares of Healthequity? Shares of HQY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Healthequity's stock price today? One share of HQY stock can currently be purchased for approximately $41.09. How big of a company is Healthequity? Healthequity has a market capitalization of $2.91 billion and generates $531.99 million in revenue each year. The company earns $39.66 million in net income (profit) each year or $1.38 on an earnings per share basis. Healthequity employs 1,141 workers across the globe. View additional information about Healthequity. What is Healthequity's official website? The official website for Healthequity is http://www.healthequity.com/. How can I contact Healthequity? Healthequity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The company can be reached via phone at 801-727-1000 or via email at [email protected] This page was last updated on 4/5/2020 by MarketBeat.com StaffFeatured Article: Why is the Consumer Price Index (CPI) important?
